1. Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial. Issue 6 (29th April 2021) Authors: McCrimmon, Rory J.; Al Sifri, Saud; Emral, Rifat; Mohan, Viswanathan; Sauque‐Reyna, Leobardo; Trescolí, Carlos; Lalic, Nebojsa; Alvarez, Agustina; Demil, Nacima; Coudert, Mathieu; Shaunik, Alka; Bonnemaire, Mireille; Rosenstock, Julio Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 6(2021) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗